Understanding how neurons respond to your drug candidate is key to bringing your CNS therapies to market.
At Aquila, we offer tailored neuronal assays to better understand the MOA of your therapeutic, de-risking your discovery program. We can screen neurons as isolated neuronal populations e.g. dopaminergic neurons in Parkinson’s Disease or as more complex mixed cell population assays. We can offer custom assay readouts in addition to the standard viability and survival tests as well as neurite outgrowth.
Using our ex vivo slice culture assay, we can study neuronal behaviour in the native environment maintaining intact synapses and circuits. With this approach, we aim to generate high-value mechanistic data that can get you to the clinic faster.
Please contact us to learn how our neuronal research services can help meet your research needs.